Shares of Inovio Pharmaceuticals Inc. INO shed 1.03% to $1.92 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.52% ...
Shares of Inovio Pharmaceuticals Inc. INO shed 1.02% to $1.94 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.33% ...
INOVIO (NASDAQ: INO) released its financial results and operational highlights for 2024, marking significant strides in its ...
3d
Inovio plans to begin submitting the BLA for INO-3107 in mid-2025, with a goal of achieving FDA acceptance for filing by year-end 2025. Priority review will also be requested.
In a report released yesterday, Gregory Renza from RBC Capital maintained a Hold rating on Inovio Pharmaceuticals (INO – Research Report), with ...
Citizens JMP lowered the firm’s price target on Inovio (INO) to $12 from $18 and keeps an Outperform rating on the shares. Inovio expressed ...
Good afternoon, ladies and gentlemen, and welcome to the INOVIO Pharmaceuticals fourth quarter 2024 financial results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback